360 related articles for article (PubMed ID: 35384591)
21. Intracranial ependymoma.
Maksoud YA; Hahn YS; Engelhard HH
Neurosurg Focus; 2002 Sep; 13(3):e4. PubMed ID: 15844876
[TBL] [Abstract][Full Text] [Related]
22. [Interdisciplinary therapy of childhood ependymomas].
Timmermann B; Kortmann RD; Kühl J; Willich N; Bamberg M
Strahlenther Onkol; 2002 Sep; 178(9):469-79. PubMed ID: 12426832
[TBL] [Abstract][Full Text] [Related]
23. Biology and management of ependymomas.
Wu J; Armstrong TS; Gilbert MR
Neuro Oncol; 2016 Jul; 18(7):902-13. PubMed ID: 27022130
[TBL] [Abstract][Full Text] [Related]
24. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
[TBL] [Abstract][Full Text] [Related]
25. Treatment and survival of supratentorial and posterior fossa ependymomas in adults.
Nuño M; Yu JJ; Varshneya K; Alexander J; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2016 Jun; 28():24-30. PubMed ID: 26810473
[TBL] [Abstract][Full Text] [Related]
26. Treatment of spinal cord ependymomas by surgery with or without postoperative radiotherapy.
Lin YH; Huang CI; Wong TT; Chen MH; Shiau CY; Wang LW; Ming-Tak Ho D; Yen SH
J Neurooncol; 2005 Jan; 71(2):205-10. PubMed ID: 15690140
[TBL] [Abstract][Full Text] [Related]
27. Spinal ependymoma in adults: from molecular advances to new treatment perspectives.
Cerretti G; Pessina F; Franceschi E; Barresi V; Salvalaggio A; Padovan M; Manara R; Di Nunno V; Bono BC; Librizzi G; Caccese M; Scorsetti M; Maccari M; Minniti G; Navarria P; Lombardi G
Front Oncol; 2023; 13():1301179. PubMed ID: 38074692
[TBL] [Abstract][Full Text] [Related]
28. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
Tauziède-Espariat A; Siegfried A; Nicaise Y; Kergrohen T; Sievers P; Vasiljevic A; Roux A; Dezamis E; Benevello C; Machet MC; Michalak S; Puiseux C; Llamas-Gutierrez F; Leblond P; Bourdeaut F; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Dangouloff-Ros V; Boddaert N; Saffroy R; Hasty L; Wahler E; Pagès M; Andreiuolo F; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
Acta Neuropathol Commun; 2021 Aug; 9(1):135. PubMed ID: 34389065
[TBL] [Abstract][Full Text] [Related]
29. Ependymomas.
Chamberlain MC
Curr Neurol Neurosci Rep; 2003 May; 3(3):193-9. PubMed ID: 12691623
[TBL] [Abstract][Full Text] [Related]
30. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.
Godfraind C; Kaczmarska JM; Kocak M; Dalton J; Wright KD; Sanford RA; Boop FA; Gajjar A; Merchant TE; Ellison DW
Acta Neuropathol; 2012 Aug; 124(2):247-57. PubMed ID: 22526017
[TBL] [Abstract][Full Text] [Related]
31. Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas.
Shatara M; Schieffer KM; Klawinski D; Thomas DL; Pierson CR; Sribnick EA; Jones J; Rodriguez DP; Deeg C; Hamelberg E; LaHaye S; Miller KE; Fitch J; Kelly B; Leraas K; Pfau R; White P; Magrini V; Wilson RK; Mardis ER; Abdelbaki MS; Finlay JL; Boué DR; Cottrell CE; Ghasemi DR; Pajtler KW; Osorio DS
Acta Neuropathol Commun; 2021 Dec; 9(1):192. PubMed ID: 34895332
[TBL] [Abstract][Full Text] [Related]
32. Updates in the classification of ependymal neoplasms: The 2021 WHO Classification and beyond.
Kresbach C; Neyazi S; Schüller U
Brain Pathol; 2022 Jul; 32(4):e13068. PubMed ID: 35307892
[TBL] [Abstract][Full Text] [Related]
33. Ependymomas of the spinal region in adults: Clinical and pathological features and MYCN expression levels in spinal ependymomas and myxopapillary ependymomas.
Topel G; Dirilenoğlu F; Sevin İE; Kahraman A
Ann Diagn Pathol; 2024 Jun; 70():152299. PubMed ID: 38555652
[TBL] [Abstract][Full Text] [Related]
34. Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior.
Swanson AA; Raghunathan A; Jenkins RB; Messing-Jünger M; Pietsch T; Clarke MJ; Kaufmann TJ; Giannini C
J Neuropathol Exp Neurol; 2019 Sep; 78(9):791-797. PubMed ID: 31373367
[TBL] [Abstract][Full Text] [Related]
35. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.
Robertson PL; Zeltzer PM; Boyett JM; Rorke LB; Allen JC; Geyer JR; Stanley P; Li H; Albright AL; McGuire-Cullen P; Finlay JL; Stevens KR; Milstein JM; Packer RJ; Wisoff J
J Neurosurg; 1998 Apr; 88(4):695-703. PubMed ID: 9525716
[TBL] [Abstract][Full Text] [Related]
36. Classification and neuroimaging of ependymal tumors.
Mu W; Dahmoush H
Front Pediatr; 2023; 11():1181211. PubMed ID: 37287627
[TBL] [Abstract][Full Text] [Related]
37. Intracranial ependymomas: molecular insights and translation to treatment.
Lester A; McDonald KL
Brain Pathol; 2020 Jan; 30(1):3-12. PubMed ID: 31433520
[TBL] [Abstract][Full Text] [Related]
38. Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors.
Wang M; Zhang R; Liu X; Li D; Qiu C; Zhao P; Zuo Y; Zhang P; Wang J; Sun H
Clin Neurol Neurosurg; 2018 Feb; 165():1-6. PubMed ID: 29253745
[TBL] [Abstract][Full Text] [Related]
39. Advances in the classification and treatment of pediatric brain tumors.
Fangusaro J; Bandopadhayay P
Curr Opin Pediatr; 2021 Feb; 33(1):26-32. PubMed ID: 33278109
[TBL] [Abstract][Full Text] [Related]
40. Pediatric glial tumors.
Cohen KJ; Broniscer A; Glod J
Curr Treat Options Oncol; 2001 Dec; 2(6):529-36. PubMed ID: 12057098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]